Ifp Advisors, Inc Gamida Cell Ltd. Transaction History

Ifp Advisors, Inc

  • $2.42 Billion
  • Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Gamida Cell Ltd. stock. As of the latest transaction made, Ifp Advisors, Inc holds 2,200 shares of GMDA stock, worth $66. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,200
Previous 200 1000.0%
Holding current value
$66
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
BUY
$0.0 - $0.04 $0 - $80
2,000 Added 1000.0%
2,200 $0
Q2 2022

Sep 06, 2022
BUY
$1.73 - $4.29 $346 - $858
200 New
200 $2,000
Q2 2022

Aug 12, 2022
SELL
$1.73 - $4.29 $346 - $858
-200 Closed
0 $0
Q1 2021

Apr 30, 2021
BUY
$7.8 - $12.43 $1,560 - $2,486
200 New
200 $2,000

Others Institutions Holding GMDA

# of Institutions
1
Shares Held
2.2K
Call Options Held
0
Put Options Held
0
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email